Relation of depression to various markers of coagulation and fibrinolysis in patients with and without coronary artery disease

Abstract

Background It

has been suggested that changes in blood coagulation and fibrinolysis might explain the observed association between depression and coronary artery disease (CAD). So far, only a few coagulation factors have been investigated in this regard, and the results were not consistent.

Design

The aim of our study was to analyse a broad range of coagulation and fibrinolytic factors, with emphasis on factors directly involved in clot formation and degradation or reflecting coagulation activation, in patients with CAD and controls without CAD, as assessed by coronary angiography, who also underwent a diagnostic procedure for depression.

Methods

We screened 306 patients with CAD and controls without CAD for depression using the Hospital Anxiety and Depression Scale and Allgemeine Depressions Skala-L questionnaires. In participants with positive screening result, diagnosis of major depression was confirmed or excluded by a structured interview. We analysed the following coagulation and fibrinolytic factors: fibrinogen, prothrombin fragment F1+2, factor XIII A-subunit, factor XIII B-subunit, tissue plasminogen activator, plasminogen activator inhibitor-1, thrombin-activable fibrinolysis inhibitor, and D-dimer.

Results

We did not observe significant associations between depression and CAD, nor between depression and cardiovascular risk factors. Coagulation and fibrinolytic factors showed no differences between patients with CAD and controls, but they were associated with several cardiovascular risk factors. Depression was not associated with coagulation and fibrinolytic factors. No associations were found either when both CAD and depression were taken into account.

Conclusion

Our study gives no evidence that there is a significant relation among depression, CAD, and blood coagulation and fibrinolysis. Eur J Cardiovasc Prev Rehabil 14: 782-787 © 2007 The European Society of Cardiology

Keywords

Keywords:coagulation coronary artery disease depression fibrinolysis

Get full access to this article

View all access options for this article.

References

Ford

Mead

Chang

Cooper-Patrick

Wang

Klag

MJ.

Depression is a risk factor for coronary artery disease in men. Arch Intern Med 1998; 158: 1422–1426.

2 Barefoot

Helms

Mark

Blumenthal

Califf

Haney

, et al. Depression and long-term mortality risk in patients with coronary artery disease. Am J Cardiol 1996; 78:613–617.

Hance

Carney

Freedland

Skala

Depression in patients with coronary heart disease. Gen Hosp Psychiatry 1996; 18:61–65.

Ladwig

Kieser

König

Breithardt

Borggrefe

Affective disorders and survival after acute myocardial infarction. Results from the post-infarction late potential study. Eur Heart J 1991; 12: 959–964.

Frasure-Smith

Lespèrance

Talajic

Depression following myocardial infarction. JAMA 1993; 270: 1819–1825.

Kaufmann

Fitzgibbons

Sussman

Reed

Einfalt

Rodgers

Fricchione

GL.

Relation between myocardial infarction, depression, hostility, and death. Am Heart J 1999; 138: 549–554.

Frasure-Smith

Lespèrance

Talajic

Depression and 18-months prognosis after myocardial infarction. Circulation 1995; 91: 999–1005.

Penninx

Beekman

Honig

Deeg

Schoevers

van Eijk

van Tilburg

Depression and cardiac mortality: results from a community-based longitudinal study. Arch Gen Psychiatry 2001; 58: 221–227.

9 Carney

Blumenthal

Catellier

Freedland

Berkman

Watkins

, et al. Depression as a risk factor for mortality after acute myocardial infarction. Am J Cardiol 2003; 92: 1277–1281.

10.

Shimbo

Davidson

Haas

Fuster

Badimon

JJ.

Negative impact of depression on outcomes in patients with coronary artery disease: mechanisms, treatment considerations, and future directions. J Thromb Haemost 2005; 3: 897–908.

11.

Meade

Ruddock

Stirling

Chakrabarti

Miller

GJ.

Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study. Lancet 1993; 342: 1076–1079.

12.

Thompson

Kienast

Pyke

Haverkate

Van de Loo

JC.

Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European concerted action on thrombosis and disabilities angina pectoris study group. N Engl J Med 1995; 332: 635–641.

13.

Folsom

Rosamond

Sharrett

Chambless

LE.

Prospective study of hemostatic factors and incidence of coronary heart disease: the atherosclerosis risks in communities (ARIC) study. Circulation 1997; 96: 1102–1108.

14.

Juhan-Vague

Morange

Alessi

CM.

Fibrinolytic function and coronary risk. Curr Cardiol Rep 1999; 1: 119–124.

15.

Kohler

Grant

PJ.

Plasminogen-activator inhibitor type 1 and coronary artery disease. N Engl J Med 2000; 342: 1792–1801.

16.

Kohler

Grant

PJ.

The role of factor XIIIVal34Leu in cardiovascular disease. QJM 1999; 92: 67–72.

17.

Mansfield

Kohler

Ariens

McCormack

Grant

PJ.

Circulating levels of coagulation factor XIII in subjects with type 2 diabetes and in their first-degree relatives. Diabetes Care 2000; 23: 703–705.

18.

18 Kohler

Ariens

Catto

Carter

Miller

Cooper

, et al. Factor XIII A-subunit concentration predicts outcome in stroke subjects and vascular outcome in healthy, middle-aged men. Br J Haematol 2002; 118: 825–832.

19.

19 Schroeder

Chatterjee

Mehta

Windecker

Pham

Devantay

, et al. Thrombin activatable fibrinolysis inhibitor (TAFI) levels in patients with coronary artery disease investigated by angiography. Thromb Haemost 2002; 88: 1020–1025.

20.

Folsom

Qamhieh

HAT

Flack

Hilner

Liu

Howard

Tracy

RP.

Plasma fibrinogen: levels and correlates in young adults. The coronary artery risk development in young adults (CARDIA) study. Am J Epidemiol 1993; 138: 1023–1036.

21.

Dentino

Pieper

Rao

Currie

Harris

Blazer

Cohen

HJ.

Association of interleukin-6 and other biologic variables with depression in older people living in the community. J Am Geriatr Soc 1999; 47: 6–11.

22.

22 Kop

Gottdiener

Tangen

Fried

McBurnie

Walston

, et al. Inflammation and coagulation factors in persons 65 years of age with symptoms of depression but without evidence of myocardial infarction. Am J Cardiol 2002; 89: 419–424.

23.

Panagiotakos

Pitsavos

Chrysohoou

Tsetsekou

Papageorgiou

Christodoulou

Stefanadis

Inflammation, coagulation, and depressive symptomatology in cardiovascular disease-free people; the ATTICA study. Eur Heart J 2004; 25: 492–499.

24.

24 Lahlou-Laforet

Alhenc-Gelas

Pornin

Bydlowski

Seigneur

Benetos

, et al. Relation of depressive mood to plasminogen activator inhibitor, tissue plasminogen activator, and fibrinogen levels in patients with versus without coronary heart disease. Am J Cardiol 2006; 97: 1287–1291.

25.

Zigmond

Snaith

RP.

The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 361–370.

26.

Hautzinger

Bailer

Allgemeine depressions Skala. manual. Göttingen: Beltz Test GmbH; 1993.

27.

Radloff

LS.

The CES-D scale: A self-report depression scale for research in the general population. Appl Psychol Meas 1977; 1: 385–401.

28.

28 Lecrubier

Sheehan

Weiller

Amorim

Bonora

Harnett

Sheehan K

, et al. The Mini International Neuropsychiatric Interview (MINI). A short diagnostic structured interview: reliability and validity according to the CIDI. Eur Psychiatry 1997; 12: 224–231.

29.

29 Sheehan

Lecrubier

Harnett

Sheehan K

Janavs

Weiller

Keskiner

, et al. The validity of the Mini International Neuropsychiatric Interview (MINI) according to the SCID-P and its reliability. Eur Psychiatry 1997; 12: 232–241.

30.

30 American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.

31.

Hamilton

A rating scale for depression. J Neurol Neurosurg Psychiat 1960; 23: 56–62.

32.

Baumann

Methodologic studies of the Hamilton rating scale for depression. Arch Psychiatr Nervenkr 1976; 222: 359–375.

33.

Ariëns

RAS

Kohler

Mansfield

Grant

PJ.

Subunit antigen and activity levels of blood coagulation factor XIII in healthy individuals. Relation to sex, age, smoking, and hypertension. Arterioscler Thromb Vasc Biol 1999; 19: 2012–2016.

34.

Kohler

HP.

Insulin resistance syndrome: interaction with coagulation and fibrinolysis. Swiss Med Weekly 2002; 132: 241–252.